Leslie Dan

Chairman- Novopharm,
(born November 26, 1929) is a Canadian businessman and philanthropist.

Born in Budapest, Dan came to Canada in 1947. As a Jewish man, he survived World War II by using false identity papers. He graduated from the University of Toronto School of Pharmacy in 1954 obtaining a Bachelor of Science degree. He completed his Master of Business Administration degree in 1959. In 1960, he founded a company which distributed over-the-counter drugs.

In 1965, he founded Novopharm. In 2000 when he sold the company to Israel's Teva Pharmaceuticals for an estimated $430 million, it had sales of $750 million and employed 3,000 people. He then started a new company, Viventia (formerly Novopharm Biotech), which specializes in the discovery and development of products for the treatment of cancer. He is currently the chairman.

Leslie Dan is Chairman of Novopharm Limited, one of Canada's leading pharmaceutical companies and Chairman of Viventia Biotech Inc. Prior to April 5, 2000, Mr. Dan was Chairman and CEO of Novopharm Limited.